CD274 and cancer: Hyperprogressive disease (HPD) is a peculiar pattern of tumor progression characterizing a fraction of patients, affected by different types of cancers, that received immune checkpoint inhibitors (ICIs), such as anti-PD1/PDL1 antibodies [1,2].